475 related articles for article (PubMed ID: 17495707)
1. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion.
Perkins JG; Schreiber MA; Wade CE; Holcomb JB
J Trauma; 2007 May; 62(5):1095-9; discussion 1099-101. PubMed ID: 17495707
[TBL] [Abstract][Full Text] [Related]
2. The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion.
Spinella PC; Perkins JG; McLaughlin DF; Niles SE; Grathwohl KW; Beekley AC; Salinas J; Mehta S; Wade CE; Holcomb JB
J Trauma; 2008 Feb; 64(2):286-93; discussion 293-4. PubMed ID: 18301188
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant factor VIIa in US military casualties for a five-year period.
Wade CE; Eastridge BJ; Jones JA; West SA; Spinella PC; Perkins JG; Dubick MA; Blackbourne LH; Holcomb JB
J Trauma; 2010 Aug; 69(2):353-9. PubMed ID: 20699744
[TBL] [Abstract][Full Text] [Related]
4. Recombinant activated coagulation factor VII and bleeding trauma patients.
Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
[TBL] [Abstract][Full Text] [Related]
5. The effects of protocolized use of recombinant factor VIIa within a massive transfusion protocol in a civilian level I trauma center.
Morse BC; Dente CJ; Hodgman EI; Shaz BH; Nicholas JM; Wyrzykowski AD; Salomone JP; Vercruysse GA; Rozycki GS; Feliciano DV
Am Surg; 2011 Aug; 77(8):1043-9. PubMed ID: 21944521
[TBL] [Abstract][Full Text] [Related]
6. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital.
Stinger HK; Spinella PC; Perkins JG; Grathwohl KW; Salinas J; Martini WZ; Hess JR; Dubick MA; Simon CD; Beekley AC; Wolf SE; Wade CE; Holcomb JB
J Trauma; 2008 Feb; 64(2 Suppl):S79-85; discussion S85. PubMed ID: 18376176
[TBL] [Abstract][Full Text] [Related]
7. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M;
Crit Care; 2006; 10(6):R178. PubMed ID: 17184516
[TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients.
Brown CV; Foulkrod KH; Lopez D; Stokes J; Villareal J; Foarde K; Curry E; Coopwood B
J Trauma; 2010 Feb; 68(2):348-52. PubMed ID: 20154547
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury.
Stein DM; Dutton RP; Kramer ME; Handley C; Scalea TM
J Trauma; 2008 Mar; 64(3):620-7; discussion 627-8. PubMed ID: 18332801
[TBL] [Abstract][Full Text] [Related]
10. The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage.
Boffard KD; Choong PI; Kluger Y; Riou B; Rizoli SB; Rossaint R; Warren B;
Transfusion; 2009 Dec; 49 Suppl 5():240S-7S. PubMed ID: 19954486
[TBL] [Abstract][Full Text] [Related]
11. The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy.
McMullin NR; Kauvar DS; Currier HM; Baskin TW; Pusateri AE; Holcomb JB
Curr Surg; 2006; 63(4):246-51. PubMed ID: 16843774
[TBL] [Abstract][Full Text] [Related]
12. [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis].
Grinţescu I; Tulbure D; Mirea L
Chirurgia (Bucur); 2006; 101(6):615-24. PubMed ID: 17283837
[TBL] [Abstract][Full Text] [Related]
13. Timing and location of blood product transfusion and outcomes in massively transfused combat casualties.
Cap AP; Spinella PC; Borgman MA; Blackbourne LH; Perkins JG
J Trauma Acute Care Surg; 2012 Aug; 73(2 Suppl 1):S89-94. PubMed ID: 22847102
[TBL] [Abstract][Full Text] [Related]
14. Early autologous fresh whole blood transfusion leads to less allogeneic transfusions and is safe.
Rhee P; Inaba K; Pandit V; Khalil M; Siboni S; Vercruysse G; Kulvatunyou N; Tang A; Asif A; O'Keeffe T; Joseph B
J Trauma Acute Care Surg; 2015 Apr; 78(4):729-34. PubMed ID: 25807402
[TBL] [Abstract][Full Text] [Related]
15. Transfusion strategies and development of acute respiratory distress syndrome in combat casualty care.
Park PK; Cannon JW; Ye W; Blackbourne LH; Holcomb JB; Beninati W; Napolitano LM
J Trauma Acute Care Surg; 2013 Aug; 75(2 Suppl 2):S238-46. PubMed ID: 23883915
[TBL] [Abstract][Full Text] [Related]
16. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.
Gelsomino S; Lorusso R; Romagnoli S; Bevilacqua S; De Cicco G; Billè G; Stefàno P; Gensini GF
Eur J Cardiothorac Surg; 2008 Jan; 33(1):64-71. PubMed ID: 17996457
[TBL] [Abstract][Full Text] [Related]
17. Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries.
Spinella PC; Perkins JG; Grathwohl KW; Beekley AC; Niles SE; McLaughlin DF; Wade CE; Holcomb JB
J Trauma; 2008 Feb; 64(2 Suppl):S69-77; discussion S77-8. PubMed ID: 18376175
[TBL] [Abstract][Full Text] [Related]
18. Increased platelet:RBC ratios are associated with improved survival after massive transfusion.
Holcomb JB; Zarzabal LA; Michalek JE; Kozar RA; Spinella PC; Perkins JG; Matijevic N; Dong JF; Pati S; Wade CE; ; Holcomb JB; Wade CE; Cotton BA; Kozar RA; Brasel KJ; Vercruysse GA; MacLeod JB; Dutton RP; Hess JR; Duchesne JC; McSwain NE; Muskat PC; Johannigamn JA; Cryer HM; Tillou A; Cohen MJ; Pittet JF; Knudson P; DeMoya MA; Schreiber MA; Tieu BH; Brundage SI; Napolitano LM; Brunsvold ME; Sihler KC; Beilman GJ; Peitzman AB; Zenati MS; Sperry JL; Alarcon LH; Croce MA; Minei JP; Steward RM; Cohn SM; Michalek JE; Bulger EM; Nunez TC; Ivatury RR; Meredith JW; Miller PR; Pomper GJ; Marin B
J Trauma; 2011 Aug; 71(2 Suppl 3):S318-28. PubMed ID: 21814099
[TBL] [Abstract][Full Text] [Related]
19. Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients.
Nascimento B; Lin Y; Callum J; Reis M; Pinto R; Rizoli S
Clinics (Sao Paulo); 2011; 66(1):101-6. PubMed ID: 21437444
[TBL] [Abstract][Full Text] [Related]
20. Massive postpartum hemorrhage: recombinant factor VIIa use is safe but not effective.
Kalina M; Tinkoff G; Fulda G
Del Med J; 2011 Apr; 83(4):109-13. PubMed ID: 21675158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
